K882

K882 (Compound 4e) is a potent Src inhibitor (K_D = 0.315 μM) that induces apoptosis and suppresses key survival proteins and oncogenic pathways, including PI3K/Akt/mTOR. It demonstrates antitumor efficacy in non-small cell lung cancer models in both cellular and in vivo studies.